All news

DSM CEO: Global economy continues to exhibit “microeconomic uncertainty and low consumer confidence”

Giant confronting omega-3, vitamin E challenges

DSM nutrition profits dip 7% in 2014

By Shane STARLING

Pricing and sector market challenges, currency fluctuations and some stiff economic headwinds have contributed to 2014 full-year EBITDA profits sliding 7% for the world’s biggest nutrient player, DSM.

There's a thin line between toxic and healthy, say researchers looking at the shifting perceptions of antioxidants

Healthy or toxic? The conflicting images of antioxidants

By Annie Harrison-Dunn

Benefit-risk ratios must be established for each antioxidant separately, considering risk groups and dosage, according to researchers reviewing polarised perceptions of vitamin E and beta-carotene.

FDA Commissioner Margaret Hamburg to step down

FDA Commissioner Margaret Hamburg to step down

By Stephen DANIELLS

The US Food and Drug Administration (FDA) has confirmed media rumours that Dr Margaret Hamburg is stepping down from her role as Commissioner at the end of March, with Stephen Ostroff, MD, the FDA's chief scientist, serving as acting Commissioner.

Sports nutrition companies differentiating based on quality, transparency

Sports nutrition companies differentiating based on quality, transparency

By Hank Schultz

The issue of “protein spiking” has led companies in the sports nutrition sphere to start to differentiate their products based on the quality and transparency of their ingredients and to rely less on marketing-driven messages of the products’ muscle-boosting...

Why start-ups will drive the future of health & wellness

Why start-ups will drive the future of health & wellness

By Julian Mellentin

Good news for would-be entrepreneurs – and even for executives inside big companies who long to create something new. In health and wellness, it is start-ups that are taking the lead in redefining markets and creating new categories. 

Standard Process hires new executive director of R&D

Standard Process hires new executive director of R&D

Wisconsin-based Standard Process has appointed Ibrahim Abou-Nemeh, PhD, as its new executive director of R&D to advance company’s research strategy and develop more new products that provide health care solutions.

NY AG takes on GNC, Walgreens, Walmart & Target on herbal supplements

GNC, Walgreens, Target and Walmart sent cease and desist letters

‘Uninformed’, ‘inappropriate’ and ‘premature’: Industry experts round on NY AG’s action against major retailers over failed DNA tests for herbal supplements

By Stephen Daniells

The New York Attorney General has sent letters to GNC, Target, Walmart, and Walgreens telling them to stop selling some herbal supplements after DNA tests found 79% didn’t contain the labeled substance or contained other non-listed ingredients. Analytical...

10 questions we need answered regarding the NY AG’s botanical action

10 questions we need answered regarding the NY AG’s botanical action

By Stephen Daniells

You couldn’t make it up: DNA barcoding is used to test products that appear to be predominantly extracts by a researcher who is more comfortable with reptiles and dinosaurs and the results have not been made public. But the NY Attorney General is using...

3 into 1: Euro probiotics sector unites as sector sales drop 8%

Insider: The three groups reached accord “surprisingly quickly”

3 into 1: Euro probiotics sector unites as sector sales drop 8%

By Shane STARLING

Europe’s three biggest probiotic groups have united behind a new European chapter of the International Probiotics Association (IPA) to deal with the “critical” 6-year regulatory imbroglio that has seen an EU-wide sales slide in the health claim-less sector.

FDA extends Redbook update comment period

FDA extends Redbook update comment period

By Stephen DANIELLS

The US Food and Drug Administration has extended the comment period for updates to the Redbook until May 11, 2015 in response to requests.

Follow us

Products

View more

Webinars